Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy.
Arthritis & rheumatology (Hoboken, N.J.)(2023)
摘要
This open-label study demonstrated abatacept may be beneficial for treatment-refractory JDM.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要